Загрузка...

Icatibant and ACE inhibitor angioedema

Icatibant is a selective bradykinin 2 receptor antagonist, currently licensed for use in hereditary angioedema. Its benefit in ACE inhibitor angioedema is yet to be fully established. A handful of preliminary case reports suggest that it may be of benefit in reducing both symptom severity and possib...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMJ Case Rep
Главные авторы: Illing, Elizabeth Janet, Kelly, Sara, Hobson, Jonathan Charles, Charters, Seema
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Group 2012
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4543926/
https://ncbi.nlm.nih.gov/pubmed/22936825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2012-006646
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!